Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China
· Delayed Price · Currency is CNY 17.71
+0.21 (1.20%)
Jul 15, 2025, 1:44 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
Adsorbed Tetanus Vaccine | 462.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Adsorbed Tetanus Vaccine Growth | 5.78% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Haemophilus Influenzae Type B Conjugate Vaccine | 27.27M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Haemophilus Influenzae Type B Conjugate Vaccine Growth | -50.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Group A and Group C Meningococcal Polysaccharide Conjugate Vaccine | 3.88M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Group A and Group C Meningococcal Polysaccharide Conjugate Vaccine Growth | -92.85% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Refined Tetanus Toxoid Stock Solution | 177.99K |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Refined Tetanus Toxoid Stock Solution Growth | 83.33% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 1.83M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | 127.76% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Tetanus Toxoid Concentrated Liquid | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Tetanus Toxoid Concentrated Liquid Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
China | 496.12M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | -9.38% |
Log In |
Log In |
Log In |
Log In | Upgrade
|